This month’s articles:
Latest articles
Pre-clinical work completed for novel COVID-19 immunotherapy
ISA Pharmaceuticals has announced that it has completed pre-clinical work for ISA106, a novel COVID-19 immunotherapy and is planning clinical trials. A phase 1...
Ashfield shakes up healthcare services with advanced integrated offering
Ashfield, part of UDG Healthcare plc, has announced the formation of three business units to bolster its integrated healthcare services across strategic consulting, benchmarking,...
Cancer Research UK and Teon collaborate on cancer drug
Cancer Research UK and Teon have signed a collaboration agreement to progress the early phase clinical development of Teon’s first-in-class small molecule adenosine A2B receptor antagonist, TT-702.
Under the terms of the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS prescription charge to increase from 1 April 2021
The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
New consultancy specialising in healthcare innovation launches
Today sees the launch of Newmarket Strategy, a strategic and technical advisory business specialising in healthcare and life sciences. This new venture brings together three...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...